# Fulgent Genetics, Inc.: Form 8-K, filed Jun 2, 2026

- Company: [Fulgent Genetics, Inc.](/companies/flgt.md) (CIK 1674930)
- Form: 8-K
- Filed: 2026-06-02
- Accepted by EDGAR: Jun 1, 2026, 19:07 ET
- Period: 2026-06-01
- Accession: 0001674930-26-000028
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674930/000167493026000028/flgt-20260601.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674930/000167493026000028/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674930/000167493026000028/flgt-20260601.htm

Filed Jun 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001674930-26-000028. Last ingested by Listed: Nov 5, 2026, 17:27 ET. No prices; not investment advice.